NYT > U.S. News With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access Par :Stephanie Nolen 24 juillet 2026 à 06:45 Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain. © Arlette Bashizi for The New York TimesHealth workers speaking with students about H.I.V. prevention drugs at the University of Zambia in Lusaka in March.
Connexion
